HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gennaro D'Amato Selected Research

anti-IgE

1/2014Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review.
11/2007A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
8/2007A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma.
3/2006Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
1/2006Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab).
9/2004Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
4/2003Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Gennaro D'Amato Research Topics

Disease

16Asthma (Bronchial Asthma)
01/2015 - 01/2002
7Inflammation
01/2015 - 09/2004
7Hypersensitivity (Allergy)
01/2015 - 09/2004
4Rhinitis
11/2007 - 04/2003
3Airway Obstruction (Choking)
10/2011 - 01/2002
3Chronic Obstructive Pulmonary Disease (COPD)
10/2011 - 01/2003
2Anaphylaxis (Anaphylactic Shock)
06/2013 - 01/2013
2Bronchial Spasm
09/2011 - 07/2009
2Immediate Hypersensitivity
05/2005 - 09/2004
2Atopic Dermatitis (Atopic Eczema)
09/2004 - 04/2003
2Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
09/2004 - 04/2003
2Food Hypersensitivity (Food Allergy)
09/2004 - 04/2003
1Latex Hypersensitivity (Latex Allergy)
01/2013
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2011
1Cough
01/2002
1Hypertension (High Blood Pressure)
01/2002

Drug/Important Bio-Agent (IBA)

10Immunoglobulin E (IgE)IBA
01/2015 - 04/2003
7anti-IgEIBA
01/2014 - 04/2003
7omalizumab (Xolair)FDA Link
01/2014 - 04/2003
6AllergensIBA
01/2015 - 04/2003
5Adrenal Cortex Hormones (Corticosteroids)IBA
01/2014 - 04/2003
4AntibodiesIBA
08/2007 - 09/2004
3Air Pollutants (Pollutants, Air)IBA
01/2015 - 01/2011
3LatexIBA
06/2013 - 11/2007
3formoterol (Oxis)FDA Link
10/2011 - 01/2003
2OzoneIBA
01/2015 - 01/2011
2Oxytocin (Pitocin)FDA LinkGeneric
06/2013 - 01/2013
2Contrast MediaIBA
09/2011 - 07/2009
2IgE Receptors (Fc epsilon RI)IBA
03/2006 - 09/2004
1Vehicle Emissions (Emissions, Vehicle)IBA
01/2015
1CytokinesIBA
01/2013
1HFA 134a (hydrofluoroalkane)IBA
10/2011
1ChlorineIBA
10/2011
1Nitrogen DioxideIBA
01/2011
1Sulfur DioxideIBA
01/2011
1Monoclonal AntibodiesIBA
11/2007
1AntigensIBA
11/2007
1Immunoglobulins (Immunoglobulin)IBA
01/2006
1Sodium Chloride (Saline Solution)FDA LinkGeneric
05/2005
1tiotropium (Spiriva)FDA Link
05/2005
1Histamine (Histamine Dihydrochloride)FDA Link
05/2005
1Immunoglobulin G (IgG)IBA
05/2005
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2005
1urapidilIBA
01/2002
1Antihypertensive Agents (Antihypertensives)IBA
01/2002
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2002
1Serotonin (5 Hydroxytryptamine)IBA
01/2002
1Angiotensin IIIBA
01/2002
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2002

Therapy/Procedure

3General Anesthesia
02/2012 - 07/2009
1Continuous Positive Airway Pressure
10/2014
1Dry Powder Inhalers
10/2011
1Metered Dose Inhalers (Metered Dose Inhaler)
10/2011
1Condoms (Condom)
11/2007